Matthew Whalen
Fortune : - $ au 31/07/2026
Fortune : - $ au 31/07/2026
Mr. Matthew P.
Whalen, CPA, is an Independent Director at MIRA Pharmaceuticals, Inc., an Independent Director at Telomir Pharmaceuticals, Inc. and a Chief Financial Officer at Power Digital Marketing, Inc. He is on the Board of Directors at MIRA Pharmaceuticals, Inc. and Telomir Pharmaceuticals, Inc. Mr. Whalen was previously employed as a Chief Financial Officer by MRC Smart Technology Solutions, Inc. He received his undergraduate degree from the University of San Diego.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 21/07/2026 | 0 ( -.--% ) | - $ | 31/07/2026 | |
| 21/07/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| TELOMIR PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 12/08/2024 |
| MIRA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 18/11/2024 |
Power Digital Marketing, Inc.
Power Digital Marketing, Inc. Advertising/Marketing ServicesCommercial Services Operates as a digital marketing agency | Directeur Financier/CFO | - |
| Sociétés | Poste | Fin |
|---|---|---|
MRC Smart Technology Solutions, Inc.
MRC Smart Technology Solutions, Inc. Commercial Printing/FormsCommercial Services Provides printing services | Directeur Financier/CFO | 01/05/2021 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
University of San Diego
University of San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Power Digital Marketing, Inc.
Power Digital Marketing, Inc. Advertising/Marketing ServicesCommercial Services Operates as a digital marketing agency | Commercial Services |
MRC Smart Technology Solutions, Inc.
MRC Smart Technology Solutions, Inc. Commercial Printing/FormsCommercial Services Provides printing services | Commercial Services |
MIRA Pharmaceuticals, Inc.
MIRA Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops and sells new molecular synthetic THC for the treatment of adult patients with anxiety and cognitive decline | Health Technology |
Telomir Pharmaceuticals, Inc.
Telomir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops a novel small molecule as the first regulator of telomere length and genomic stability | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national